GSK Asks Senate To Rethink Patent Reform Act

Law360, New York (January 19, 2008, 12:00 AM EST) -- The chief executive of pharmaceutical giant GlaxoSmithKline Plc has urged senators to rethink a key provision of the Patent Reform Act, according to a letter acquired by the PLI patent blog.

In the letter obtained by patent attorney Gene Quinn, editor and lead contributor to the blog, GSK objected to a section of the Senate bill that would require patent applicants to submit an exhaustive search report, including a patentability analysis and a search of prior art.

That provision, the letter said, puts no bounds on...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.